Details
Stereochemistry | ACHIRAL |
Molecular Formula | C10H16N2O3 |
Molecular Weight | 212.2456 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCC1(CC)C(=O)NC(=O)NC1=O
InChI
InChIKey=STDBAQMTJLUMFW-UHFFFAOYSA-N
InChI=1S/C10H16N2O3/c1-3-5-6-10(4-2)7(13)11-9(15)12-8(10)14/h3-6H2,1-2H3,(H2,11,12,13,14,15)
DescriptionCurator's Comment: description was created based on several sources, including:
http://www.doctoralia.co.uk/medication/soneryl-10028 | http://www.minclinic.ru/drugs/drugs_eng/S/Soneryl.html
Curator's Comment: description was created based on several sources, including:
http://www.doctoralia.co.uk/medication/soneryl-10028 | http://www.minclinic.ru/drugs/drugs_eng/S/Soneryl.html
Butethal is a sedative and a hypnotic drug indicated for the treatment of severe intractable insomnia. It acts on receptors in the brain (GABA A receptors) causing the release of the chemical GABA. This chemical inhibits certain areas of the brain resulting in sleepiness. Common side effects are: drowsiness, sedation, unsteadiness, vertigo and inco- ordination. Also, hangover effect, paradoxical excitement, confusion, memory defects and skin rashes. Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).
CNS Activity
Originator
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: http://www.ndrugs.com/?s=neonal&t=dosage
100-200 mg at bedtime
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/6267224
Butethal enhanced GABA binding to rat brain synaptosomal membranes in a dose-dependent manner with the threshold concentration at 6.25 uM.
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-VATC |
QN05CA03
Created by
admin on Fri Dec 15 14:59:35 GMT 2023 , Edited by admin on Fri Dec 15 14:59:35 GMT 2023
|
||
|
LIVERTOX |
132
Created by
admin on Fri Dec 15 14:59:35 GMT 2023 , Edited by admin on Fri Dec 15 14:59:35 GMT 2023
|
||
|
NCI_THESAURUS |
C67084
Created by
admin on Fri Dec 15 14:59:35 GMT 2023 , Edited by admin on Fri Dec 15 14:59:35 GMT 2023
|
||
|
DEA NO. |
2100
Created by
admin on Fri Dec 15 14:59:35 GMT 2023 , Edited by admin on Fri Dec 15 14:59:35 GMT 2023
|
||
|
WHO-ATC |
N05CA03
Created by
admin on Fri Dec 15 14:59:35 GMT 2023 , Edited by admin on Fri Dec 15 14:59:35 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DB01353
Created by
admin on Fri Dec 15 14:59:35 GMT 2023 , Edited by admin on Fri Dec 15 14:59:35 GMT 2023
|
PRIMARY | |||
|
229336
Created by
admin on Fri Dec 15 14:59:35 GMT 2023 , Edited by admin on Fri Dec 15 14:59:35 GMT 2023
|
PRIMARY | |||
|
449
Created by
admin on Fri Dec 15 14:59:35 GMT 2023 , Edited by admin on Fri Dec 15 14:59:35 GMT 2023
|
PRIMARY | |||
|
C87459
Created by
admin on Fri Dec 15 14:59:35 GMT 2023 , Edited by admin on Fri Dec 15 14:59:35 GMT 2023
|
PRIMARY | |||
|
201-019-9
Created by
admin on Fri Dec 15 14:59:35 GMT 2023 , Edited by admin on Fri Dec 15 14:59:35 GMT 2023
|
PRIMARY | |||
|
m2794
Created by
admin on Fri Dec 15 14:59:35 GMT 2023 , Edited by admin on Fri Dec 15 14:59:35 GMT 2023
|
PRIMARY | Merck Index | ||
|
6473
Created by
admin on Fri Dec 15 14:59:35 GMT 2023 , Edited by admin on Fri Dec 15 14:59:35 GMT 2023
|
PRIMARY | |||
|
BUTOBARBITAL
Created by
admin on Fri Dec 15 14:59:35 GMT 2023 , Edited by admin on Fri Dec 15 14:59:35 GMT 2023
|
PRIMARY | |||
|
19874
Created by
admin on Fri Dec 15 14:59:35 GMT 2023 , Edited by admin on Fri Dec 15 14:59:35 GMT 2023
|
PRIMARY | RxNorm | ||
|
OHZ8QAW6YC
Created by
admin on Fri Dec 15 14:59:35 GMT 2023 , Edited by admin on Fri Dec 15 14:59:35 GMT 2023
|
PRIMARY | |||
|
CHEMBL404422
Created by
admin on Fri Dec 15 14:59:35 GMT 2023 , Edited by admin on Fri Dec 15 14:59:35 GMT 2023
|
PRIMARY | |||
|
SUB13135MIG
Created by
admin on Fri Dec 15 14:59:35 GMT 2023 , Edited by admin on Fri Dec 15 14:59:35 GMT 2023
|
PRIMARY | |||
|
DTXSID70227808
Created by
admin on Fri Dec 15 14:59:35 GMT 2023 , Edited by admin on Fri Dec 15 14:59:35 GMT 2023
|
PRIMARY | |||
|
C027712
Created by
admin on Fri Dec 15 14:59:35 GMT 2023 , Edited by admin on Fri Dec 15 14:59:35 GMT 2023
|
PRIMARY | |||
|
77-28-1
Created by
admin on Fri Dec 15 14:59:35 GMT 2023 , Edited by admin on Fri Dec 15 14:59:35 GMT 2023
|
PRIMARY | |||
|
100000076905
Created by
admin on Fri Dec 15 14:59:35 GMT 2023 , Edited by admin on Fri Dec 15 14:59:35 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)